Binding proteins specific for insulin-like growth factors and uses thereof

Details for Australian Patent Application No. 2011203010 (hide)

Owner AstraZeneca AB

Inventors Raeber, Olivia; Gazit-Bornstein, Gadi; Yang, Xiaodong; Cartlidge, Susan Ann; Tonge, David William

Agent Davies Collison Cave

Pub. Number AU-A-2011203010

Parent 2006326649

Filing date 21 June 2011

Wipo publication date 14 July 2011

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

7 July 2011 Complete Application Filed

14 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203010

20 October 2011 Assignment before Grant

  AstraZeneca AB The application has been assigned to MedImmune Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203011-Granulated metallic iron superior in rust resistance and method for producing the same

2011203009-A method of controlling an update of game code in a gaming system